Clincosm LogoSign in Get a demo

Pancreatic Cancer

Showing NaN - NaN of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Pancreatic Cancer Trial in New Orleans, Dallas (XB2001 or Placebo)

Recruiting
  • Pancreatic Cancer
  • XB2001 or Placebo
  • Tucson, Arizona
  • +27 more
Jan 27, 2023

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +11 more
    • New Haven, Connecticut
    • +12 more
    Nov 3, 2022

    Pancreatic Cancer Trial in Birmingham, Nashville (Point-of-care Portable Perfusion Phantom, P4)

    Recruiting
    • Pancreatic Cancer
    • Point-of-care Portable Perfusion Phantom, P4
    • Birmingham, Alabama
    • +1 more
    Nov 3, 2022

    Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +11 more
    • Part 1 TPST-1120
    • +3 more
    • San Francisco, California
    • +10 more
    Nov 1, 2022

    Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +5 more
    • RSC-1255 Dose Escalation
    • RSC-1255 Dose Expansion
    • Los Angeles, California
    • +5 more
    Oct 24, 2022

    Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Gilbert, Arizona
    • +16 more
    Sep 13, 2022

    Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))

    Recruiting
    • Pancreatic Cancer
    • Scottsdale, Arizona
    • +3 more
    Aug 17, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

    Active, not recruiting
    • Solid Tumor
    • +4 more
    • Nashville, Tennessee
    • +14 more
    Jul 21, 2022

    Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

    Recruiting
    • Advanced Malignant Neoplasm
    • +5 more
    • AMXI-5001:Dose Escalation Phase I
    • AMXI-5001:Dose Expansion Phase II
    • Phoenix, Arizona
    • +7 more
    Jul 18, 2022

    Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

    Recruiting
    • Mesothelioma
    • +14 more
    • TC-510
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 14, 2022

    Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

    Recruiting
    • Any Advanced Solid Tumors
    • +6 more
    • Tampa, Florida
    • +7 more
    Jul 13, 2022

    Tissue and Biological Fluid Samples From Patients and Healthy

    Recruiting
    • Colorectal Cancer
    • +4 more
    • protein analysis
    • +10 more
    • Nashville, Tennessee
    • +3 more
    Jul 7, 2022

    Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

    Recruiting
    • Oncology
    • +16 more
    • E-602
    • Pembrolizumab
    • Grand Rapids, Michigan
    • +4 more
    May 27, 2022

    Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

    Recruiting
    • Metastatic Cancer
    • +4 more
    • Phoenix, Arizona
    • +15 more
    Mar 9, 2022

    Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

    Completed
    Has Results
    • Advanced Solid Tumors
    • +6 more
    • Cabiralizumab
    • Nivolumab
    • Scottsdale, Arizona
    • +38 more
    Jan 5, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

    Recruiting
    • HER2-positive
    • +30 more
    • CT-0508
    • Duarte, California
    • +4 more
    Feb 1, 2022

    Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

    Completed
    • Breast Cancer
    • +5 more
    • Nashville, Tennessee
    • +11 more
    Jan 28, 2022

    Depression, Fatigue, Stage IIA Colorectal Cancer Trial in Winston-Salem, Nashville (Laboratory Biomarker Analysis, Questionnaire

    Completed
    Has Results
    • Depression
    • +20 more
    • Laboratory Biomarker Analysis
    • +5 more
    • Winston-Salem, North Carolina
    • +1 more
    Jan 5, 2022

    NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in United States (NBF-006)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Beverly Hills, California
    • +8 more
    Dec 21, 2021